Copperleaf Capital, LLC
Annual return '25
+2.6%
SPY '25
+17.7%
Alpha
-15.1ptsvs SPY
Invested
$273M
Holdings
24
Trades YTD
0
Performance · Fund vs SPY
Cumulative return · quarterly snapshotsCoverage 99%. 4 quarters of 2025 measured against SPY adj-close benchmark.
Top holdings · current snapshot
Source: 13F-HR01
$SKYE
SKYE BIOSCIENCE INC
Held since at least Q1 2024
14.0%
02
$TRDA
ENTRADA THERAPEUTICS INC
Held since at least Q1 2024
9.1%
03
$PHVS
PHARVARIS N V
Held since at least Q1 2024
7.3%
04
$CAMP
CAMP4 THERAPEUTICS CORP
Held since at least Q1 2024
6.5%
05
$CNTA
CENTESSA PHARMACEUTICALS PLC
Held since at least Q1 2024
6.1%
06
$VRDN
VIRIDIAN THERAPEUTICS INC
Held since at least Q1 2024
5.9%
07
$ELVN
ENLIVEN THERAPEUTICS INC
Held since at least Q1 2024
5.8%
08
$EYPT
EYEPOINT PHARMACEUTICALS INC
Held since at least Q1 2024
5.5%
09
$DNTH
DIANTHUS THERAPEUTICS INC
Held since at least Q1 2024
5.3%
10
$TYRA
TYRA BIOSCIENCES INC
Held since at least Q1 2024
4.8%
Recent trades · Last 90 days
No Form 4 / 13D / 13G trade events on file in the recent window. 13F filers report position snapshots quarterly rather than per-trade events, so this section is most useful for managers who also file Form 4 or 13D/G.
Convergence · Pattern Engine ships in v1.1
30-day windowIn development
Convergence participation lands with the Pattern Engine.
Once the Pattern Engine ships, this section will list every active convergence event this fund is named in — with the other named funds, the Congress members on the same name, and combined position size.
Source data: SEC EDGAR · 13F-HR filings · Performance through 2025-12-31 · Last refreshed 12:10 UTC.